The present study aimed to investigate whether YAP activation plays a role in obesity-associated endothelial dysfunction and inflammation and examine whether the vasoprotective effect of metformin is related to YAP inhibition. The gene discussed is YAP1; the disease is obesity due to melanocortin 4 receptor deficiency.